Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment

• Saud N. Al Sifri ,

  * E-mail: saudnafa@hotmail.com

  Affiliation Endocrinology Department, Al Hada Military Hospitals, Taif, Saudi Arabia

  ⨯
• Wael Almahmeed,

  Affiliation Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

  ⨯
• Sami Azar,

  Affiliation American University of Beirut Medical Center, Beirut, Lebanon

  ⨯
• Osama Okkeh,

  Affiliation Istishari Hospital, Amman, Jordan

  ⨯
• Peter Bramlage,

  Affiliation Institut für Pharmakologie und präventive Medizin, Mahlow, Germany

  ⨯
• Claus Jünger,

  Affiliations Institut für Herzinfarktforschung, Ludwigshafen, Germany, University Medical Center, Johannes Gutenberg University, Mainz, Germany

  ⨯
• Islam Halawa,

  Affiliation Medical Department, MSD Saudi Arabia, Riyadh, Saudi Arabia

  ⨯
• Baishali Ambegaonkar,

  Affiliation Merck & Co., Inc., Whitehouse Station, New Jersey, United States of America

  ⨯
• Sameh Wajih,

  Affiliation Medical Department, MSD United Arab Emirates, Abu Dhabi, United Arab Emirates

  ⨯
• Philippe Brudi

  Affiliation Merck & Co., Inc., Whitehouse Station, New Jersey, United States of America

  ⨯